Nifty Midcap 100 59597.8 (-0.20)
Nifty Pharma 22562.3 (-0.47)
Nifty 50 25732.3 (-0.22)
SENSEX 83627.69 (-0.30)
Nifty Bank 59578.8 (0.22)
Nifty IT 38236.55 (0.65)
Nifty Next 50 68522 (-0.26)
Nifty Smallcap 100 17295.8 (0.60)
NIKKEI 225 53549.16 (3.10)
HANG SENG 26848.47 (0.90)
S&P 6969.32 (-0.41)
23-May-2025
Net down 98% on weak operating show
'Consolidated net sales (including other operating income) of WPIL for the quarter ended Mar 2025 has declined 3.30% to Rs 571.87 crore. Operating profit margin has declined from 17.29% to 13.97%, leading to 21.86% decline in operating profit to Rs 79.91 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 22.03% to 28.18%. Employee cost increased from 7.92% to 10.71%. Other expenses fell from 53.62% to 46.68%. Contract job process charges fell from 42.87% to 33.56%. Other income fell 45.96% to Rs 5.75 crore. PBIDT fell 24.13% to Rs 85.66 crore. Provision for interest rose 65.66% to Rs 11.53 crore. PBDT fell 30.03% to Rs 74.13 crore. Provision for depreciation rose 18.15% to Rs 9.44 crore. Profit before tax down 33.96% to Rs 64.69 crore. Share of profit/loss was 94.63% lower at Rs 0.08 crore. Provision for tax was e...
(05-Feb-2025)
Expects EBITDA margin of 22%-25% for CY25
(10-Feb-2023)
Plans capex of about Rs 1500 crore for FY23 and FY24
(09-Feb-2023)
Targets revenue of Rs 1000 crore in FY24
(31-Jan-2023)
Capex plan is US$ 30-32 million for next three years
Analyst Meet / AGM-Conference Call (25-Nov-2025)
International projects margins have started improving and are expected to normalize
Results-Analysis (20-Aug-2025)
Net down 42% as OPM stay low
Analyst Meet / AGM-Conference Call (06-Aug-2025)
Optimistic about H2FY26
Results-Analysis (23-May-2025)